Mergers & Acquisitions ·
Galmed Pharmaceuticals Ltd. consummated the acquisition of Colospan Ltd. on June 22, 2026, following an amended share…
GLMDGalmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd. consummated the acquisition of Colospan Ltd. on June 22, 2026, following an amended share purchase agreement that replaced $2.0 million in equity with $800,000 in cash, resulting in an aggregate cash consideration of $3,300,000. The deal includes up to $2.0 million in performance-based earnout consideration tied to cumulative Net Sales Revenues starting July 1, 2027, with specific tiered levels and a cap. Galmed Pharmaceuticals Ltd. is a pharmaceutical company focused on developing and commercializing medical treatments.